SE0100193D0 - Method for the preparation of citalopram - Google Patents

Method for the preparation of citalopram

Info

Publication number
SE0100193D0
SE0100193D0 SE0100193A SE0100193A SE0100193D0 SE 0100193 D0 SE0100193 D0 SE 0100193D0 SE 0100193 A SE0100193 A SE 0100193A SE 0100193 A SE0100193 A SE 0100193A SE 0100193 D0 SE0100193 D0 SE 0100193D0
Authority
SE
Sweden
Prior art keywords
citalopram
preparation
palladium catalyst
zinc
cyanide
Prior art date
Application number
SE0100193A
Other languages
English (en)
Other versions
SE0100193L (sv
SE516690C2 (sv
Inventor
Hans Petersen
Michael Harold Rock
Henrik Svane
Original Assignee
Lundbeck & Co As H
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lundbeck & Co As H filed Critical Lundbeck & Co As H
Publication of SE0100193D0 publication Critical patent/SE0100193D0/sv
Publication of SE0100193L publication Critical patent/SE0100193L/sv
Publication of SE516690C2 publication Critical patent/SE516690C2/sv

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/87—Benzo [c] furans; Hydrogenated benzo [c] furans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A61K31/343—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide condensed with a carbocyclic ring, e.g. coumaran, bufuralol, befunolol, clobenfurol, amiodarone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J23/00—Catalysts comprising metals or metal oxides or hydroxides, not provided for in group B01J21/00
    • B01J23/38—Catalysts comprising metals or metal oxides or hydroxides, not provided for in group B01J21/00 of noble metals
    • B01J23/40—Catalysts comprising metals or metal oxides or hydroxides, not provided for in group B01J21/00 of noble metals of the platinum group metals
    • B01J23/44—Palladium
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/78—Benzo [b] furans; Hydrogenated benzo [b] furans
    • C07D307/79—Benzo [b] furans; Hydrogenated benzo [b] furans with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
    • C07D307/81—Radicals substituted by nitrogen atoms not forming part of a nitro radical

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • Materials Engineering (AREA)
  • Rheumatology (AREA)
  • Psychiatry (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Catalysts (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Steroid Compounds (AREA)
SE0100193A 1999-06-25 2001-01-24 Förfarande för framställning av citalopram SE516690C2 (sv)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DKPA199900920 1999-06-25
PCT/DK1999/000640 WO2000013648A2 (en) 1999-06-25 1999-11-22 Method for the preparation of citalopram

Publications (3)

Publication Number Publication Date
SE0100193D0 true SE0100193D0 (sv) 2001-01-24
SE0100193L SE0100193L (sv) 2001-04-25
SE516690C2 SE516690C2 (sv) 2002-02-12

Family

ID=8099035

Family Applications (1)

Application Number Title Priority Date Filing Date
SE0100193A SE516690C2 (sv) 1999-06-25 2001-01-24 Förfarande för framställning av citalopram

Country Status (36)

Country Link
US (2) US20020077353A1 (sv)
EP (1) EP1159274B1 (sv)
JP (1) JP3447267B2 (sv)
KR (1) KR100491368B1 (sv)
CN (2) CN1140521C (sv)
AR (1) AR020863A1 (sv)
AT (3) AT409961B (sv)
AU (2) AU1374500A (sv)
BG (1) BG65574B1 (sv)
BR (1) BR9917368B1 (sv)
CA (2) CA2475401A1 (sv)
CH (1) CH691305A5 (sv)
CZ (1) CZ292198B6 (sv)
DE (2) DE19983487C1 (sv)
DK (2) DK1159274T3 (sv)
EA (1) EA002560B1 (sv)
ES (2) ES2194545T3 (sv)
FI (1) FI108641B (sv)
GB (2) GB2354239B (sv)
HK (1) HK1049002B (sv)
HU (1) HUP0103235A3 (sv)
IL (2) IL145959A0 (sv)
IS (1) IS2343B (sv)
IT (1) ITMI991581A1 (sv)
MX (1) MXPA01010989A (sv)
NO (1) NO328542B1 (sv)
NZ (1) NZ514979A (sv)
PL (1) PL205579B1 (sv)
PT (1) PT1159274E (sv)
SE (1) SE516690C2 (sv)
SI (1) SI1159274T1 (sv)
SK (1) SK285813B6 (sv)
TR (1) TR200103702T2 (sv)
UA (1) UA63034C2 (sv)
WO (1) WO2000013648A2 (sv)
ZA (1) ZA200108854B (sv)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2356188C (en) 1998-12-23 2006-05-23 H. Lundbeck A/S Method for the preparation of 5-cyanophthalide
AR022329A1 (es) 1999-01-29 2002-09-04 Lundbeck & Co As H Metodo para la preparacion de 5-cianoftalida
NZ514671A (en) 1999-04-14 2003-10-31 H Method for the preparation of citalopram
ITMI991579A1 (it) 1999-06-25 2001-01-15 Lundbeck & Co As H Metodo per la preparazione di citalopram
ES2229774T3 (es) 1999-10-25 2005-04-16 H. Lundbeck A/S Metodo para la preparacion de citalopram.
DK1228056T3 (da) 1999-10-25 2005-01-24 Lundbeck & Co As H Fremgangsmåde til fremstilling af citalopram
AR026063A1 (es) 1999-11-01 2002-12-26 Lundbeck & Co As H Metodo para la preparacion de 5-carboxiftalida.
JP2003519136A (ja) 1999-12-28 2003-06-17 ハー・ルンドベック・アクチエゼルスカベット シタロプラムの製造方法
DE69912652T2 (de) 1999-12-30 2004-06-09 H. Lundbeck A/S Verfahren zur herstellung von citalopram
SI1254129T1 (en) 2000-01-14 2004-02-29 H. Lundbeck A/S Method for the preparation of 5-cyanophthalide
FR2805812A1 (fr) 2000-02-24 2001-09-07 Lundbeck & Co As H Procede de preparation du citalopram
NL1017417C1 (nl) 2000-03-03 2001-03-16 Lundbeck & Co As H Werkwijze voor de bereiding van Citalopram.
NZ521201A (en) 2000-03-13 2004-02-27 H Method for the preparation of citalopram
GB2357762B (en) 2000-03-13 2002-01-30 Lundbeck & Co As H Crystalline base of citalopram
NL1017500C1 (nl) 2000-03-13 2001-04-26 Lundbeck & Co As H Werkwijze voor de bereiding van Citalopram.
EP1265881A1 (en) 2000-03-13 2002-12-18 H. Lundbeck A/S Stepwise alkylation of 5-substituted 1-(4-fluorophenyl)-1,3-dihydroisobenzofurans
MXPA02008653A (es) 2000-03-14 2003-02-24 Lundbeck & Co As H Metodo para la preparacion de citalopram.
JP2003527388A (ja) * 2000-03-16 2003-09-16 ハー・ルンドベック・アクチエゼルスカベット ５−シアノ−１−（４−フルオロフェニル）−１，３−ジヒドロイソベンゾフランの製造方法
AR032455A1 (es) 2000-05-12 2003-11-12 Lundbeck & Co As H Metodo para la preparacion de citalopram, un intermediario empleado en el metodo, un metodo para la preparacion del intermediario empleado en el metodo y composicion farmaceutica antidepresiva
CA2383963A1 (en) * 2000-07-06 2002-01-17 Eva Bolzonella Method for the preparation of citalopram
CA2354877C (en) * 2000-08-18 2006-05-02 H. Lundbeck A/S Method for the preparation of citalopram
NL1017525C1 (nl) 2000-12-22 2001-04-26 Lundbeck & Co As H Werkwijze voor de bereiding van zuiver Citalopram
IL147162A0 (en) * 2000-12-28 2002-08-14 Lundbeck & Co As H Process for the preparation of pure citalopram
EP1355897A1 (en) 2001-01-30 2003-10-29 Orion Corporation Fermion Process for the preparation of 1-(3-dimethylaminopropyl)-1-(4-fluorophenyl)-1,3-dihydroisobenzofuran-5-carbonitrile
GB0105627D0 (en) * 2001-03-07 2001-04-25 Cipla Ltd Preparation of phthalanes
JP2005500256A (ja) * 2001-03-09 2005-01-06 ランバクシー ラボラトリーズ リミテッド シタロプラム製造方法
US6967259B2 (en) * 2001-09-24 2005-11-22 Pharmachem Technologies Limited Process for the preparation of Citalopram intermediate
AU2003222435A1 (en) * 2002-01-07 2003-07-24 Sun Pharmaceutical Industries Limited Process for the preparation of 1-(3-(dimethylamino)propyl)-1-(4-fluorophenyl)- 1,3-dihydro-5-isobenzofuran carbonitrile
AR040970A1 (es) 2002-08-12 2005-04-27 Lundbeck & Co As H Metodo para la separacion de intermediarios que pueden ser utilizados para la preparacion de escitalopram
US20050154052A1 (en) * 2003-03-24 2005-07-14 Hetero Drugs Limited Novel crystalline forms of (s)-citalopram oxalate
US7019153B2 (en) 2003-06-10 2006-03-28 Sun Pharmaceutical Industries Limited Process for hydrogenolysis of [1-(3-dimethylamino)propyl)]-1-(4-fluorophenyl)-1,3-dihydro-5-halo-isobenzofuran acetamido-3-substituted-3-cephem-4-carboxylic acid
TWI339651B (en) 2004-02-12 2011-04-01 Lundbeck & Co As H Method for the separation of intermediates which may be used for the preparation of escitalopram
WO2006021971A2 (en) 2004-08-23 2006-03-02 Sun Pharmaceutical Industries Limited 'process for preparation of citalopram and enantiomers'
US7834201B2 (en) 2005-06-22 2010-11-16 H. Lundbeck A/S Crystalline base of escitalopram and orodispersible tablets comprising escitalopram base
TWI358407B (en) 2005-06-22 2012-02-21 Lundbeck & Co As H Crystalline base of escitalopram and orodispersibl
EP2017271A1 (en) 2007-07-06 2009-01-21 Aurobindo Pharma Limited Process for the preparation of escitalopram

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1143703A (sv) * 1965-03-18
GB1526331A (en) * 1976-01-14 1978-09-27 Kefalas As Phthalanes
GB8419963D0 (en) * 1984-08-06 1984-09-12 Lundbeck & Co As H Intermediate compound and method
GB8814057D0 (en) * 1988-06-14 1988-07-20 Lundbeck & Co As H New enantiomers & their isolation
DK213290D0 (da) * 1990-09-06 1990-09-06 Lundbeck & Co As H Treatment of cerebrovascular disorders
US5296507A (en) * 1990-09-06 1994-03-22 H.Lundbeck A/S Treatment of cerbrovascular disorders
DE19626659A1 (de) * 1996-07-03 1998-01-08 Basf Ag Verfahren zur Herstellung von Phthaliden
DE19627697A1 (de) * 1996-07-10 1998-01-15 Basf Ag Verfahren zur Herstellung von Phthaliden
KR100357975B1 (ko) * 1997-07-08 2002-10-25 하. 룬트벡 아크티에 셀스카브 시탈로프램의 제조방법
UA62985C2 (en) * 1997-11-10 2004-01-15 Lunnbeck As H A method for the preparation of citalopram
CN1286687A (zh) * 1997-11-11 2001-03-07 H·隆德贝克有限公司 制备西酞普兰的方法
DE69904853T2 (de) * 1998-10-20 2003-09-04 Lundbeck As Valby H Verfahren zur herstellung von citalopram
CA2356188C (en) * 1998-12-23 2006-05-23 H. Lundbeck A/S Method for the preparation of 5-cyanophthalide
AR022329A1 (es) * 1999-01-29 2002-09-04 Lundbeck & Co As H Metodo para la preparacion de 5-cianoftalida
NZ514671A (en) * 1999-04-14 2003-10-31 H Method for the preparation of citalopram
ITMI991579A1 (it) * 1999-06-25 2001-01-15 Lundbeck & Co As H Metodo per la preparazione di citalopram
ES2229774T3 (es) * 1999-10-25 2005-04-16 H. Lundbeck A/S Metodo para la preparacion de citalopram.
AR026063A1 (es) * 1999-11-01 2002-12-26 Lundbeck & Co As H Metodo para la preparacion de 5-carboxiftalida.
FR2805812A1 (fr) * 2000-02-24 2001-09-07 Lundbeck & Co As H Procede de preparation du citalopram
IES20010143A2 (en) * 2000-02-24 2001-07-25 Lundbeck & Co As H Method for the preparation of citalopram
CA2354877C (en) * 2000-08-18 2006-05-02 H. Lundbeck A/S Method for the preparation of citalopram
NL1017525C1 (nl) * 2000-12-22 2001-04-26 Lundbeck & Co As H Werkwijze voor de bereiding van zuiver Citalopram
IL147162A0 (en) * 2000-12-28 2002-08-14 Lundbeck & Co As H Process for the preparation of pure citalopram

Also Published As

Publication number Publication date
CN1367786A (zh) 2002-09-04
US20090088469A1 (en) 2009-04-02
PL205579B1 (pl) 2010-05-31
GB2357761B (en) 2001-09-05
GB2354239A (en) 2001-03-21
KR20020012204A (ko) 2002-02-15
ZA200108854B (en) 2002-08-28
WO2000013648A3 (en) 2000-07-13
FI20010155A (sv) 2001-02-09
UA63034C2 (en) 2004-01-15
AU2001100440A4 (en) 2001-11-01
GB0101504D0 (en) 2001-03-07
AU2001100440B4 (en) 2002-01-24
EP1159274A2 (en) 2001-12-05
AT409961B (de) 2002-12-27
NO328542B1 (no) 2010-03-15
CA2290127A1 (en) 2000-12-25
JP2002526386A (ja) 2002-08-20
CZ292198B6 (cs) 2003-08-13
EA002560B1 (ru) 2002-06-27
ATA904199A (de) 2002-05-15
DK200100060A (da) 2001-04-10
SK18402001A3 (sk) 2002-06-04
DK1159274T3 (da) 2003-07-21
GB2357761A (en) 2001-07-04
FI108641B (sv) 2002-02-28
HK1049002B (zh) 2004-12-31
AR020863A1 (es) 2002-05-29
CN1140521C (zh) 2004-03-03
SE0100193L (sv) 2001-04-25
ITMI991581A0 (it) 1999-07-15
JP3447267B2 (ja) 2003-09-16
PT1159274E (pt) 2003-08-29
IS5861A (is) 2001-02-23
IL145959A (en) 2007-07-24
HUP0103235A3 (en) 2003-01-28
PL346237A1 (en) 2002-01-28
BG106191A (en) 2002-08-30
WO2000013648A2 (en) 2000-03-16
MXPA01010989A (es) 2002-06-04
KR100491368B1 (ko) 2005-05-24
BR9917368B1 (pt) 2010-02-09
WO2000013648A8 (en) 2000-05-11
CA2475401A1 (en) 2000-12-25
SI1159274T1 (en) 2003-10-31
GB0105182D0 (en) 2001-04-18
ES2189699A1 (es) 2003-07-01
SE516690C2 (sv) 2002-02-12
ITMI991581A1 (it) 2001-01-15
DE19983487C1 (de) 2002-07-25
BR9917368A (pt) 2002-03-05
US20020077353A1 (en) 2002-06-20
IL145959A0 (en) 2002-07-25
AT4365U1 (de) 2001-06-25
TR200103702T2 (tr) 2002-06-21
NZ514979A (en) 2004-01-30
AU1374500A (en) 2000-03-27
CA2290127C (en) 2005-01-25
ATE235478T1 (de) 2003-04-15
EA200101072A1 (ru) 2002-02-28
NO20010319L (no) 2001-02-23
HUP0103235A2 (hu) 2002-01-28
WO2000013648B1 (en) 2001-03-15
DE69906389T2 (de) 2003-10-30
BG65574B1 (bg) 2009-01-30
EP1159274B1 (en) 2003-03-26
CH691305A5 (de) 2001-06-29
DE69906389D1 (de) 2003-04-30
CZ2001320A3 (en) 2001-05-16
GB2354239B (en) 2001-06-06
NO20010319D0 (no) 2001-01-19
IS2343B (is) 2008-02-15
CN1502616A (zh) 2004-06-09
HK1049002A1 (en) 2003-04-25
ES2194545T3 (es) 2003-11-16
SK285813B6 (sk) 2007-08-02

Similar Documents

Publication Publication Date Title
SE0100193D0 (sv) Method for the preparation of citalopram
FR16C0033I2 (fr) Methode de formation de composes d'hydroxypyrone de fer
SE0100194L (sv) Förfarande för framtällning av citalopram
DK1438321T5 (da) Modificeret L-nukleinsyre
TR200103847T2 (tr) 3-Hidroksipropanal hazırlanması için usul
DE69923580D1 (de) Verstärkte katalysierte reporterabscheidung
ATE537266T1 (de) Verfahren zur herstellung von gold- oder silber- nanopartikeln
FR2826961B1 (fr) Procede de preparation d'anhydride (meth) acrylique
DE59701074D1 (de) Elektromagnetisches relais und verfahren zu dessen herstellung
DE60325573D1 (de) Verwendung von metallgluconatsalzen bei der herstellung von antimikrobiell wirksamen substraten
IL157495A0 (en) Method for the production of d-panthothenic acid and/or salts thereof as adjunct for animal feedstuffs
PL331419A1 (en) Method of grafting a substituted difluoromethyl group
DE602004004810D1 (de) Herstellungsverfahren für optisch reine 2-(4-hydroxyphenoxy)-propionsäureverbindungen
DK1404844T3 (da) Fremgangsmåde til fremstilling af 2,4-dideoxyhexoser og 2,4,6-trideoxyhyxoser
EA199800349A1 (ru) Способ получения гипофосфита никеля
AR020097A1 (es) Sal de n-terc-butilhidroxilamina con acidos carboxilicos c1-4 y procesos para su preparacion, aislacion y purificacion.
ATE130292T1 (de) Hydrierung.
DE59701119D1 (de) Verfahren zur herstellung eines elektromagnetischen relais
DE59803284D1 (de) Verfahren zur herstellung von acetophenonen, die am aromatischen kern mit fluoralkyl substituiert sind
DK0924195T3 (da) Fremgangsmåde til fremstilling af aminocyanacetamid
SE0101323D0 (sv) New process
ES2160491A1 (es) Secuencia aminoacida apta para afectar la actividad enzimatica de pectin metilesterasas (pme) y secuencia nucleotica para enzimas que afectan petin metilesterasas comprendiendo dicha secuencia aminoacida.
EA200100064A1 (ru) Способ получения замещенных пиридинкарбоновых кислот
MXPA04000513A (es) Proceso para la preparacion de 4-metilamino-4-fenilpiperidina.
ES2186165T3 (es) Procedimiento para preparar 3-isocromanona.

Legal Events

Date Code Title Description
NUG Patent has lapsed